Healthcare Professionals
Evolving Design. Advancing Predictability.
iStent inject® W represents the next generation of Glaukos trabecular micro-bypass technology, which has been proven safe and effective in hundreds of thousands of eyes worldwide. iStent inject® W creates two bypass pathways through the trabecular meshwork, resulting in multi-directional flow through Schlemm’s canal, and is advancing the standard of care for glaucoma patients.
Learn MoreA Breakthrough for Glaucoma Treatment
Discover how MIGS is helping eye care professionals and patients effectively manage intraocular pressure like never before.
Learn MoreTwo Outflow Pathways. One New Standard.
Learn how iStent inject® W, when used in conjunction with cataract surgery, is transforming the treatment of glaucoma.
Learn MoreOur Comprehensive Support. Your Uncompromising Patient Care.
Integrating iStent inject® W into your practice helps you expand care, and provide a wider range of benefits to many of your patients. As a trusted industry leader—and the corporate founder of MIGS—we have the experience, tools, and training to make integration easy.
Learn MoreCommitment to Eye Care Professionals
Join us at one of our upcoming events and discover the latest technology and surgical options used to lower intraocular pressure in glaucoma patients.
Learn MoreAs a service to Our Customers, Glaukos Provides a Reimbursement & Billing Guide
ReimbursementRequest the iStent inject® W posters presented at ARVO 2021
Five posters presented at ARVO 2021 highlight the efficacy and safety of the iStent platform as compared to other procedures.
Request Clinical Information